Johnson Controls International (JCI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
8 Jun, 2026Executive summary
Q2 sales rose 8% to $6.14B, with organic sales up 6% year-over-year, driven by strong demand in data centers and advanced manufacturing, especially in the Americas.
Orders increased 30% year-over-year, with backlog up 26% to a record $20B, supporting future revenue visibility.
Adjusted EPS grew 45% year-over-year to $1.19, exceeding guidance; GAAP EPS was $0.99.
Business system initiatives engaged over 1,400 colleagues, driving operational improvements and scaling best practices.
Continued innovation in proprietary chiller subsystems and digital platforms enabled high-performance, energy-efficient solutions for mission-critical environments.
Financial highlights
Q2 net sales reached $6.14B, up 8% year-over-year; gross profit was $2.26B with a 36.8% margin.
Adjusted EBIT margin expanded to 15.5%, up 310 basis points year-over-year.
Adjusted net income attributable to shareholders was $734M; adjusted free cash flow for Q2 was $526M.
Diluted EPS from continuing operations was $0.99; adjusted EPS was $1.19, up 45% year-over-year.
Cash provided by operating activities for six months was $1.28B, up from $799M year-over-year.
Outlook and guidance
Full-year FY26 organic sales growth guidance raised to ~6%; adjusted EPS outlook increased to ~$4.85 (up ~30% year-over-year).
Q3 guidance: organic sales growth ~6%, operating leverage ~45–50%, adjusted EPS ~$1.28.
Adjusted free cash flow conversion expected at ~100% for the year.
Restructuring plan targets $400M in one-time costs and $500M in annual cost savings by fiscal 2027.
Full-year adjusted corporate expense projected at ~$390M, amortization expense at ~$345M, and tax rate at ~17%.
Latest events from Johnson Controls International
- Q3 delivered growth, margin expansion, record backlog, and major divestitures amid portfolio shift.JCI
Q3 20248 Jun 2026 - Q4 organic sales up 10%, margin expansion, record backlog, and strong FY25 outlook.JCI
Q4 20248 Jun 2026 - Q1 2025 saw 10% organic growth, 39% EPS gain, and raised full-year guidance.JCI
Q1 20258 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Record backlog, strong execution, and robust capital returns set up double-digit EPS growth in 2026.JCI
Q4 20258 Jun 2026 - Sales, EPS, and backlog hit records, with raised FY26 guidance and strong demand across regions.JCI
Q1 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026 - Strong order growth, margin gains, and strategic focus drive optimism for future performance.JCI
19th Annual Global Transportation & Industrials Conference20 May 2026